Cardiovascular Journal of Africa: Vol 26 No 2 (March/April 2015)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 2, March/April 2015

AFRICA

33. Demopoulos D, Hendson W, Technau K, Cilliers AM. Vasculopathy

in HIV-infected children- a case series.

SAfr J Child Health

2009;

(1):

27–30.

34. Calabrese LH, Estes M, Yen-Lieberman B,

et al

. Systemic vasculitis

in association with human immunodeficiency virus infection.

Arthritis

Rheum

1989;

(5): 569–576.

35. Blignaut G, Loggenberg E, de Vries C. The radiological appearance of

intracranial aneurysms in adults infected with the human immunodefi-

ciency virus (HIV).

S Afr J Rad

2014;

(1): 1–4.

36. Bonkowsky JL, Christenson JC, Nixon GW, Pavia AT. Cerebral aneu-

rysms in a child with acquired immune deficiency syndrome during

rapid immune reconstitution.

J Child Neurol

2002;

: 457–460.

37. Bulsara KR, Raja A, Owen J. HIV and cerebral aneurysms.

Neurosurg

Rev

2005;

: 92–95.

38. Julie AA, Erickson JC, Lowry KJ. Cerebral aneurysmal arteriopathy

associated with HIV infection in an adult.

Clin Infect Dis

2006;

e46–e50.

39. Mazzoni P, Chiriboga CA, Millar WS, Rogers A. Intracerebral aneu-

rysms in human immunodeficiency virus infection: case report and

literature review.

Pediatr Neurol

2000;

: 252–255.

40. Modi G, Ranchod K, Modi M, Mochan A. Human immunodeficiency

virus associated intracranial aneurysms: report of three adult patients

with an overview of the literature.

J Neurol Neurosurg

2008;

: 44–46.

41. Mnguni P. Vascular lesions associated with HIV.

S Afr J Radiol

2006;

(4): 14–17.

42. O’Charoen P, Hesselink JR, Healy JF. Cerebral aneurysmal arteriopathy

in an adult patient with acquired immunodeficiency syndrome.

Am J

Neuroradiol

2007;

: 938–939.

43. Patsalides AD, Wood LV, Atac GK, Butman JA, Patronas NJ.

Cerebrovascular Disease in HIV-infected paediatric patients: neuroim-

aging findings.

Am J Radiol

2002;

179

: 999–1003.

44. Stanley A, Candy S, Levin C, Heckmann JM. The complexity of HIV

vasculopathy.

S Afr Med J

2012;

102

(6): 474–476.

45. Tipping B, De Villiers L, Candy S, Wainwright H. Stroke caused by

human immunodeficiency virus-associated intracranial large-vessel

aneurysmal vasculopathy.

Arch Neurol

2006;

: 1640–1642.

46. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive

patients: another vasculitic enigma.

Hum Pathol

2000;

(3): 374–379.

47. Van Marle J, Tudhope L, Weir G, Botes K. Vascular Disease in HIV/

AIDS patients.

S Afr Med J

2002;

(12): 74–78.

48. Botes K, van Marle J. Surgical intervention for HIV related vascular

disease.

Eur J Vasc Endovasc Surg

2007;

(4): 390–396.

49. Blyth D. Human immunodeficiency virus disease and cardiac surgery-

where are we?

SAHeart

2009;

(4): 210–220.

50. George R, Przybojewski S, Theron S. Endovascular treatment of femo-

ral artery pseudoaneurysm in a HIV positive patient – a case report.

Eur

J Vasc Endovasc Surg Extra

2007;

: 79–81.

51. Piccinato CE, Cherri J, Moriya T, Souza AC. Pseudoaneurysms of large

arteries associated with AIDS.

Sao Paulo Med J/Rev Paul Med

1999;

117

(4): 165–170.

52. Padayachy V, Robbs JV. Carotid artery aneurysms in patients with

human immunodeficiency virus.

J Vasc Surg

2012;

(2): 331–337.

53. Scholtz L. Vascular manifestations of HIV/AIDS.

Cardiovasc Interven

Radiol

2004

;

(5): 422–426.

54. Delgado Almandoz JE, Crandall BM, Fease JL, Scholz JM, Anderson

RE, Kadkhodayan Y, Tubman DE. Successful endovascular treatment

of three fusiform cerebral aneurysms with the pipeline embolization

device in a patient with dilating HIV vasculopathy.

J Neurointerv Surg

2014;

(2): e12.

55. Euringer W, Südkamp M, Rylski B, Blanke P. Endovascular treatment

of multiple HIV-related aneurysms using multilayer stents.

Cardiovasc

Interven Radiol

2012;

: 945–949.

56. Sfyroeras GS, Dalainas I, Giannakopoulos TG, Antonopoulos K,

Kakisis JD, Liapis CD. Flow-diverting stents for the treatment of arte-

rial aneurysms.

J Vasc Surg

2012;

: 839–846.

57. Lin PH, Bush RL, Yao Q,

et al

. Abdominal aortic surgery in patients

with human immunodeficiency virus infection.

Am J Surg

2004;

188

(6):

690–697.

58. Van Marle J, Mistry PP, Botes K. HIV-occlusive vascular disease.

S Afr

J Surg

2009;

(2): 36–42.

59. Nair R, Robbs JV, Chetty R, Naidoo NG, Woolgar J. Occlusive arte-

rial disease in HIV-infected patients: a preliminary report.

Eur J Vasc

Endovasc Surg

2000;

(4): 353–357.

60. Robbs JV. Pathogenesis and pathology of HIV-related large-vessel

disease.

S Afr J Surg

2009;

(2): 44–45.

61. Micheletti RG, Fishbein GA, Currier JS, Singer EJ, Fishbein MC.

Calcification of the internal elastic lamina of coronary arteries.

Mod

Pathol

2008;

(8): 1019–1028.

62. Nair R, Chetty R, Woolgar J, Naidoo NG, Robbs JV. Spontaneous

arteriovenous fistula resulting from HIV arteritis.

J Vasc Surg

2000;

(1): 186–187.

63. Felicio AC, Silva GS, dos Santos WAC, Pieri A, Gabbai AA, Massaro

AR. Spontaneous artery dissection in a patient with human immu-

nodeficiency virus (HIV) infection.

Arq Neuropsiquiatr

2006;

(2A):

306–308.

64. Barry R. The future of HIV vasculopathy when our patients are on

antiretroviral therapy.

S Afr J Surg

2009;

(2): 58–60.

65. Barry R. How does vascular disease associated with retroviral infection

differ from atherosclerosis?

S Afr J Anaesthes Analg

2010;

(1): 51–53.

66. Friis-Møller N, Sabin CA, Weber R,

et al

. Data collection on adverse

events of anti-HIV drugs (DAD) study group. Combination antiretro-

viral therapy and the risk of myocardial infarction.

N Engl J Med

2003;

349

(21); 1993–2003.

67. Ho JE, Hsue PY. Cardiovascular manifestations of HIV infection.

Heart

2009;

(14): 1193–1202.

68. Lo J, Grinspoon S. Cardiovascular disease in HIV-infected patients:

does HIV infection in and of itself increase cardiovascular risk?

Curr

Opin HIV AIDS

2008;

(3): 207–213.

69. Maggi P, Maserati R, Antonelli G. Atherosclerosis in HIV patients: a

new face for an old disease?

AIDS Rev

2006;

(4): 204–219.

70. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB.

Human immunodeficiency virus infection, AIDS, and smoking cessa-

tion: the time is now.

Clin Infect Dis

2000;

(3): 808–812.

71. Hakeem A, Bhatti S, Cilingiroglu M. The spectrum of atherosclerotic

coronary artery disease in HIV patients.

Curr Atheroscler Rep

2010;

(2): 119–124.

72. Madiba TE, Muckart DJJ, Thomson SR. Human immunodeficiency

disease: how should it affect surgical decision making?

World J Surg

2009;

(5): 899–909.

73. Fourie CMT, Van Rooyen JM, Schutte AE. HIV infection and cardio-

vascular risk in black South Africans.

Cardiovasc J Afr

2011;

(3):

117–118.

74. Fourie C, Van Rooyen J, Pieters M, Conradie K, Hoekstra T, Schutte A.

Is HIV-1 infection associated with endothelial dysfunction in a popula-

tion of African ancestry in South Africa?

Cardiovasc J Afr

2011;

(3):

134–140.

75. Periard D, Cavassini M, Taffé P,

et al

. Swiss HIV Cohort Study. High

prevalence of peripheral arterial disease in HIV-infected persons.

Clin

Infect Dis

2008;

: 761–767.

76. Hammer SM, Eron JJ Jr, Reiss P,

et al

. International AIDS Society-